We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
ZEPZELCA lurbinectedin 4 mg powder for solution for infusion 1 vial per carton, Specialised Therapeutics Australia Pty Ltd, CON-1250
Product name
ZEPZELCA lurbinectedin 4 mg powder for solution for infusion 1 vial per carton
Sponsor name
Specialised Therapeutics Australia Pty Ltd
Batches
3E016A1
Consent start
Consent no.
CON-1250
Duration
The consent is effective from 27 June 2024 until 31 October 2025.
Standard
Paragraph 8(1)(l) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not contain the information required by 8(1)(l) in relation to the preparation and storage of the prepared medicine on the label or on a package insert.
Conditions imposed
A ‘Dear Healthcare Provider’ letter identical to that provided to the TGA on 20 June 2024 will be supplied with each affected batch describing where the package insert information containing the information required under 8(1)(l) can be found.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines